Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Vaccine: X
|
October 14, 2022
Could a <i>Shigella</i> vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a <i>Shigella</i> vaccine public health value proposition, March 24 and 29, 2021
Karoun H Bagamian, Chloe Puett, John D Anderson, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
ACS Medicinal Chemistry Letters
|
February 5, 2014
Potent and selective inhibitors of CDPK1 from <i>T. gondii</i> and <i>C. parvum</i> based on a 5-aminopyrazole-4-carboxamide scaffold
Zhongsheng Zhang, Kayode K Ojo, Ramasubbarao Vidadala, et al.
ACS Medicinal Chemistry Letters
|
December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1
Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
International Journal for Parasitology
|
October 13, 2016
Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy
Kayode K Ojo, Sriveny Dangoudoubiyam, Shiv K Verma, et al.
Vaccine: X
|
October 14, 2022
Could a <i>Shigella</i> vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a <i>Shigella</i> vaccine public health value proposition, March 24 and 29, 2021
Karoun H Bagamian, Chloe Puett, John D Anderson, et al.
The Journal of Infectious Diseases
|
November 14, 2018
Pharmacokinetics and In Vivo Efficacy of Pyrazolopyrimidine, Pyrrolopyrimidine, and 5-Aminopyrazole-4-Carboxamide Bumped Kinase Inhibitors against Toxoplasmosis
Matthew A Hulverson, Igor Bruzual, Erin V McConnell, et al.
ACS Medicinal Chemistry Letters
|
February 5, 2014
Potent and selective inhibitors of CDPK1 from <i>T. gondii</i> and <i>C. parvum</i> based on a 5-aminopyrazole-4-carboxamide scaffold
Zhongsheng Zhang, Kayode K Ojo, Ramasubbarao Vidadala, et al.
ACS Medicinal Chemistry Letters
|
December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1
Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Journal of Medicinal Chemistry
|
June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis
Rama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Page
of 2